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The glyoxalase system consists of two enzymes, lactoylglutathione lyase
(glyoxalase I, GLX1)2 and hydroxyacylglutathione hydrolase (glyoxalase II,
GLX2), that act coordinately to convert a variety of ␣-ketoaldehydes into
hydroxy acids in the presence of glutathione (1). Aromatic and aliphatic
␣-ketoaldehydes react spontaneously with glutathione to form thiohemiacetals, which are converted to S-(2-hydroxyacyl)glutathione derivatives by
GLX1. GLX2 hydrolyzes S-(2-hydroxyacyl)glutathione derivatives to
regenerate glutathione and produce hydroxy acids. Glyoxalase I, a Zn(II) or
Ni(II) metalloprotein, can utilize a number of ␣-ketoaldehydes (2). However, the primary physiological substrate of the enzyme is thought to be
methylglyoxal (MG), a cytotoxic and mutagenic compound that is formed
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primarily as a by-product of carbohydrate and lipid metabolism (3, 4). MG
can react with DNA to form modified guanylate residues (5) and interstrand cross-links (6). It also reacts with proteins to form glycosylamine
derivatives of arginine and lysine and hemithioacetals with cysteines (7).
Cells with high glycolytic rates exhibit high rates of methylglyoxal
formation and increased levels of GLX1 activity. For instance, increased
levels of GLX1 and GLX2 RNA and protein have been detected in tumor
cells, including breast carcinoma cells (8). Because selective inhibition of
the glyoxalase system could cause cellular toxicity, the glyoxalase
enzymes have been investigated as potential anti-tumor and anti-malarial targets in animal systems (1, 9). Inhibitors of GLX1 and GLX2 can
inhibit the growth of tumor cells in vitro (10, 11) and in vivo (12) and
have been shown to have anti-proliferative effects on parasitic infections
(13). Finally, increased MG levels have been implicated with several
complications associated with diabetes mellitus (1, 14, 15), and changes
in glyoxalase enzymes have been linked with neurodegenerative disease
(16). Therefore, high levels of MG and the glyoxalase enzymes are associated with several aspects of human disease.
GLXI has been studied extensively in a number of systems with
biochemical, computational, and x-ray crystallographic studies providing considerable insight into its kinetic mechanism (reviewed in
Refs. 17 and 18). Insight into the kinetic mechanism of GLX1 has
allowed the development of new classes of mechanism-based, competitive inhibitors that can inhibit tumor growth in vitro and in vivo
(12, 19, 20).
Considerably less is known about the structure, reaction mechanism,
and physiological role(s) of GLX2. In contrast to GLX1, which is found
as a single isozyme, GLX2 exists as multiple isozymes in many organisms, including yeast, plants, and animals. GLX2 activity has been found
in both the cytosol and mitochondria (21–23). Furthermore, GLX2
isozymes were found in both the matrix and inter-membrane space of
rat liver mitochondria (24, 25). In most cases, separate genes encode the
cytosolic and mitochondrial isozymes. However, in humans a single
gene produces both cytosolic and mitochondrial GLX2 (21). Therefore,
the physiological role(s) of GLX2 may be more complex than GLX1.
S-D-Lactoylglutathione (SLG) appears to be the preferred substrate
for GLX2 from most sources, including human, yeast, and plants
(26 –33). However, GLX2 can hydrolyze many different glutathione
thioesters, including S-D-mandeloylglutathione, S-D-acetylglutathione, S-D-acetoacetylglutathione, S-D-formylglutathione, S-D-glycolylglutathione, and S-D-lactonylglutathione. Most interestingly,
glyoxalase II isolated from African trypanosomes prefers thioesters of
trypanothione as substrates (34).
GLX2 is one of many protein families characterized to date that contain a metallo-␤-lactamase fold. The metallo-␤-lactamases typically
bind Zn(II) (35, 36), whereas the rubredoxin:oxygen oxidoreductase and
ZiPD families contain di-Fe and di-Zn centers, respectively (37, 38).
Arabidopsis cytoplasmic GLX2 (GLX2-2) can bind Zn(II), Fe, and Mn
(39 – 41), whereas the human enzyme was reported to bind two Zn(II)
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Glyoxalase 2 is a ␤-lactamase fold-containing enzyme that
appears to be involved with cellular chemical detoxification.
Although the cytoplasmic isozyme has been characterized from several organisms, essentially nothing is known about the mitochondrial proteins. As a first step in understanding the structure and
function of mitochondrial glyoxalase 2 enzymes, a mitochondrial
isozyme (GLX2-5) from Arabidopsis thaliana was cloned, overexpressed, purified, and characterized using metal analyses, EPR and
1
H NMR spectroscopies, and x-ray crystallography. The recombinant enzyme was shown to bind 1.04 ⴞ 0.15 eq of iron and 1.31 ⴞ
0.05 eq of Zn(II) and to exhibit kcat and Km values of 129 ⴞ 10 sⴚ1
and 391 ⴞ 48 M, respectively, when using S-D-lactoylglutathione
as the substrate. EPR spectra revealed that recombinant GLX2-5
contains multiple metal centers, including a predominant Fe(III)Zn(II) center and an anti-ferromagnetically coupled Fe(III)Fe(II)
center. Unlike cytosolic glyoxalase 2 from A. thaliana, GLX2-5 does
not appear to specifically bind manganese. 1H NMR spectra
revealed the presence of at least eight paramagnetically shifted resonances that arise from protons in close proximity to a Fe(III)Fe(II)
center. Five of these resonances arose from solvent-exchangeable
protons, and four of these have been assigned to NH protons on
metal-bound histidines. A 1.74-Å resolution crystal structure of the
enzyme revealed that although GLX2-5 shares a number of structural features with human GLX2, several important differences
exist. These data demonstrate that mitochondrial glyoxalase 2 can
accommodate a number of different metal centers and that the predominant metal center is Fe(III)Zn(II).

Structure of Mitochondrial Glyoxalase 2

EXPERIMENTAL PROCEDURES
General—PCR reagents, Deep Vent DNA polymerase, restriction
enzymes (NdeI and XhoI), and S-D-lactoylglutathione were purchased
from Sigma and New England Biolabs (Beverly, MA). Primers were
synthesized by Integrated DNA Technologies (Coralville, IA). All chro3

S. Rhee and C. A. Makaroff, unpublished results.
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FIGURE 1. Sequence alignment of GLX2-5 from A. thaliana and GLX2 from human.
The numbering is based on the GLX2-5 sequence.

matographic steps were carried out on a fast protein liquid chromatography (FPLC; Amersham Biosciences) system operating at 4 °C. Columns and resins for FPLC were purchased from Amersham
Biosciences. All protein and DNA quantitations were performed on an
Agilent 8453 UV-visible spectrophotometer.
Overexpression and Purification of Arabidopsis GLX2-5—PCR was
conducted on a GLX2-5 cDNA (39), with the primers CTCCCATATGCAAATTGAACTGGTGCCTT and CGAGGATCCTCGGTCGACGCTTTTTTTTTTTTTTTTT, which generated (NdeI and XhoI)
sites at the 5⬘ and 3⬘ ends of the fragment, respectively. For expression in
Escherichia coli, the leader sequence was removed by placing the N-terminal methionine at amino acid 71 of the predicted protein sequence.
This construct yielded a protein with the same N terminus as the cytoplasmic form of the enzyme (Fig. 1). The 975-bp GLX2-5 PCR fragment
was cloned into pT7-7 by using NdeI and XhoI. The resulting plasmid,
GLX2-5/pT7-7, was transformed into DH10B E. coli cells, and the construct was verified by DNA sequencing.
The GLX2-5/pT7-7 plasmid was transformed into E. coli BL21
(DE3)-Rosetta cells and used for overexpression and protein purification as described previously (31). Protein production was induced by
making the culture 0.2 mM in isopropyl thio-␤-D-galactoside, and the
culture was made 250 M in Fe(NH4)2(SO4)2 and Zn(SO4)2. After
induction at 15 °C for 24 h, the cells were harvested, washed three times
with cold, sterile double distilled H2O to remove salts, and the cell
pellets were stored at ⫺80 °C until further use.
The cell pellet was resuspended in 30 ml of 10 mM MOPS, pH 7.2,
containing 0.1 mM phenylmethylsulfonyl fluoride. The cells were lysed
by passage twice through a French press at 16,000 p.s.i., and the cell
debris was removed by centrifugation at 12,500 rpm for 45 min. The
cleared supernatant was purified using fast protein liquid chromatography (FPLC) with a Q-Sepharose column as described previously (31).
Enzyme concentrations were determined by measuring the absorbance
at 280 nm and using a molar extinction coefficient of 37,800 M⫺1cm⫺1.
The molar extinction coefficient was determined by particle-induced
x-ray emission (PIXE) experiments (46), which were conducted by Dr.
W. Meyer-Klaucke at EMBL Outstation, Hamburg, Germany, as
described previously (38).
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ions (42). The crystal structure of human cytoplasmic GLX2 showed
that one metal-binding site consisted of three conserved histidine residues, a bridging aspartic acid, and a bridging water/hydroxide. The second metal-binding site had 2 histidines, 1 bridging Asp, 1 terminally
bound Asp, 1 bridging water/hydroxide, and 1 terminally bound water
(42). These crystallographic data have shown that the structures of the
metal-binding and active sites of GLX2 are similar to those of metallo␤-lactamase L1 from Stenotrophomonas maltophilia (43). It has been
suggested recently that subtle differences in the metal-binding ligands
of ␤-lactamase fold-containing proteins may be responsible for differences in metal binding properties between the different enzymes (44).
This theory is supported by mutational studies on Arabidopsis GLX2-2,
which have shown that mutations both inside and outside the metalbinding ligands can affect the relative amount and identity of metal
bound by the enzyme (39). Therefore, metallo-␤-lactamase fold-containing enzymes can bind several different metals and catalyze a number
of different reactions.
The presence of mitochondrial isoforms of GLX2 is intriguing
because the GLX1 and its product SLG have only been observed in the
cytosol (1). Yet mitochondrial GLX2 from several sources appears to
utilize SLG as its preferred substrate (24, 26, 28). Furthermore, overall
sequence identity between the cytoplasmic and mitochondrial enzymes
is typically limited to 30 – 40%. Thus, the physiological substrate(s) and
the role(s) of mitochondrial GLX2 are not clear, and further research is
required in order to obtain more detailed information on the mitochondrial enzymes.
In an effort to better understand the specific roles of the different
GLX2 isozymes as well as to correlate structural and functional features
of this important class of enzymes, we have begun a characterization of
the GLX2 isozymes in Arabidopsis thaliana. Five genes have been identified to encode putative GLX2 isozymes in A. thaliana (23). In addition
to GLX2-2, three GLX2 isozymes are localized in mitochondria
(GLX2-1, GLX2-4, and GLX2-5). The fifth GLX2-like gene, glx2-3,
encodes a protein that lacks many of the conserved substrate-binding
residues and may not in fact encode a functional GLX2 enzyme.3 To
date, detailed structural and kinetic studies have only been conducted
on the cytoplasmic isozyme of GLX2 (39 – 41). A mitochondrial GLX2
isozyme has not been studied in detail from any organism. Therefore,
we have overexpressed, purified, and characterized the mitochondrial
GLX2-5 isozyme from Arabidopsis using metal analysis, EPR and 1H
NMR spectroscopies, and x-ray crystallography.
Biochemical studies indicate that GLX2-5 is a FeZn protein that has a
preference for SLG as its substrate. Multiple metal centers, including an
anti-ferromagnetically coupled Fe(III)Fe(II) center, were identified by
EPR spectra, but EPR and the crystal structure analysis showed that the
predominant form of the enzyme contains an Fe(III)Zn(II) center.
These results represent the first detailed structural characterization
of a mitochondrial GLX2 enzyme from any source. They demonstrate
for the first time that ␤-lactamase fold-containing proteins can accommodate mixed metal centers and provide new insights into structurefunction features associated with GLX2 enzymes in particular and
␤-lactamase fold-containing enzymes in general.

Structure of Mitochondrial Glyoxalase 2
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RESULTS
Overexpression, Purification, and Characterization of GLX2-5—Sequence comparisons of different GLX2 isozymes in Arabidopsis showed
that GLX2-5 has a relatively long N-terminal extension that is predicted
to target it for localization in the mitochondrion (23). To overexpress
GLX2-5 in E. coli, this N-terminal leader was removed during subcloning to generate an N terminus of the protein, MQIELVP, which is similar to that in cytosolic GLX2-2 (23). This modified gene was inserted
into pT7-7 to generate the overexpression plasmid glx2-5/pT7-7. This
construct was transformed into E. coli BL21(DE3) Rosetta cells, and
small scale growth cultures were used to optimize overexpression conditions for GLX2-5.
During purification using Q-Sepharose chromatography, GLX2-5
eluted from the column at ⬃125 mM NaCl, pH 7.2. SDS-PAGE showed
that the purified enzyme was ⬎95% pure (data not shown). The eluted
protein was initially light blue in color; however, the coloration faded
within 15–30 min. The procedure described under “Experimental Procedures” resulted in the highest yield of soluble, overexpressed GLX2-5,
and resulted in ⬃50 mg of purified GLX2-5 from a 1-liter of culture.
Metal analyses on GLX2-5, overexpressed in the presence of 250 M
Fe(NH4)2(SO4)2 and Zn(SO4)2 in the culture medium, resulted in a purified recombinant enzyme that bound 1.04 ⫾ 0.15 eq of iron, 1.31 ⫾ 0.05
eq of Zn(II), 0.016 ⫾ 0.02 eq of manganese, and ⬍0.001 eq of copper.
When GLX2-5 was overexpressed in media with no added iron or zinc,
the resulting enzyme bound 0.61 ⫾ 0.07 eq of iron, 0.58 ⫾ 0.15 eqof
Zn(II), and no detectable amounts of manganese or copper. Even
though this latter sample of GLX2-5 still bound approximately equal
amounts of Fe and Zn, the total metal content of the enzyme was
roughly only 1.0. Therefore, the overexpression and purification procedure described under “Experimental Procedures” was used to prepare
GLX2-5 for all subsequent studies.
Most glyoxalase II enzymes showed a preference for S-D-lactoylglutathione as the substrate, but as described above, SLG has not yet been
found in the mitochondrion. Therefore, seven related thioesters of glutathione were used to determine the substrate preference of GLX2-5.
The substrates used were S-lactoylglutathione, S-mandeloylglutathione, S-acetylglutathione, S-acetoacetylglutathione, S-formylglutathione, S-glycolylglutathione, and S-lactonylglutathione. Initial rate
assays on these substrates showed that SLG was the preferred substrate.
It showed an initial rate of hydrolysis of 2.96 ⫻ 10⫺6 M s⫺1. S-Acetoacetylglutathione (1.33 ⫻ 10⫺6 M s⫺1) and S-glycolylglutathione (0.90 ⫻
10⫺6 M s⫺1) were hydrolyzed at about half the rate of SLG, whereas
S-mandeloylglutathione (0.35 ⫻ 10⫺6 M s⫺1), S-acetylglutathione
(0.32 ⫻ 10⫺6 M s⫺1), and S-lactonylglutathione (0.29 ⫻ 10⫺6 M s⫺1) were
hydrolyzed at rates about 10-fold lower than SLG. S-Formylglutathione
was not utilized as a substrate by GLX2-5.
Steady-state kinetic studies were then conducted on recombinant
GLX2-5 at 25 °C using SLG as the substrate. The enzyme exhibited a kcat
of 129 ⫾ 10 s⫺1 and a Km of 391 ⫾ 48 M. These values are on the order
of those observed for Arabidopsis GLX2-2, suggesting that SLG is the
preferred substrate for GLX2-5.
Spectroscopic Studies on GLX2-5—The EPR spectrum of GLX2-5
(Fig. 2) is complex containing four distinct components. The two main
components of the spectrum are interpreted to result from a proteinbound, magnetically isolated Fe(III) ion and an anti-ferromagnetically
spin-coupled Fe(II)-Fe(III) system, which are described in detail below.
In addition, the spectrum contains several minor components. Two of
the minor components are likely contaminating species; adventitiously
bound Mn(II) gives rise to a six-line pattern centered at geff. ⫽ 2.0 and an
isotropic signal at geff. ⫽ 4.3 indicative of the presence of mononuclear
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Metal Analyses—Metal analyses were performed on a Varian-Liberty
150 inductively coupled plasma spectrometer with atomic emission
spectroscopy detection as described elsewhere (31). The concentration
of GLX2-5 was 10 M in 10 mM MOPS buffer, pH 7.2. A calibration
curve with five standards and a correlation coefficient of greater than
0.998 was generated using Zn, Mn, Fe, and Cu reference solutions. The
following emission wavelengths were chosen to ensure the lowest detection limits possible: Zn, 213.856 nm; Mn, 257.610 nm; Fe, 259.940 nm;
and Cu, 324.754 nm. Metal concentrations were obtained and averaged
from at least three enzyme preparations.
Steady-state Kinetic Studies—A series of thiol esters of glutathione
were used for the preliminary investigation of substrate preferences of
GLX2-5. The substrates used were S-D-lactoylglutathione (SLG, ⑀240
3,100 M⫺1 cm⫺1), S-mandeloylglutathione (⑀263 4,200 M⫺1 cm⫺1),
S-acetylglutathione (⑀240 2,980 M⫺1 cm⫺1), S-acetoacetylglutathione
(⑀240 3,400 M⫺1 cm⫺1), S-formylglutathione (⑀240 3,300 M⫺1 cm⫺1),
S-glycolylglutathione (⑀⑀240 3,260 M⫺1 cm⫺1), and S-lactonylglutathione (⑀⑀240 3,310 M⫺1 cm⫺1). With the exception of SLG, all substrates
were synthesized as described elsewhere (47). Thiol ester hydrolysis was
monitored at 240 nm (except S-mandeloylglutathione, 263 nm) over
30 s at 25 °C. The concentrations of substrate and enzyme used were 200
and 10 M, respectively.
The steady-state kinetic parameters of the GLX2-5-catalyzed hydrolysis of S-D-lactoylglutathione were determined at 25 °C in 10 mM
MOPS, pH 7.2, using an Agilent 5483 Diode Array UV-visible spectrophotometer. The rate of hydrolysis was monitored by measuring the
absorbance at 240 nm from 30 to 600 M S-D-lactoylglutathione over a
30-s reaction period, and the data were analyzed as reported previously
(31).
EPR Spectroscopy—EPR spectra were recorded on a Bruker ESP-300E
spectrometer equipped with an Oxford Instruments ESR-900 helium
flow cryostat operating at 4.7 K with 2 milliwatts of microwave power at
9.48 GHz and employing 10-G field modulation at 100 kHz. EPR samples contained 345 M GLX2-5 in 10 mM MOPS, pH 7.2.
1
H NMR Spectroscopy—NMR samples of GLX2-5 contained ⬃10%
D2O for locking, and the concentration was 1.8 mM. The samples in
D2O were made by performing three or more dilution/concentration
cycles in a Centricon-10 to a final concentration of 1.6 –1.8 mM. The
samples were then loaded into Wilmad 5-mm tubes for NMR. NMR
spectra were collected on a Bruker Avance 500 spectrometer operating
at 500.13 MHz, 298 K, and a magnetic field of 11.7 tesla, recycle delay
(AQ), 41 ms; sweep width, 400 ppm. Protein chemical shifts were calibrated by assigning the H2O signal the value of 4.70 ppm. A modified
presaturation pulse sequence (zgpr) was used to suppress the proton
signals originating from water molecules.
X-ray Crystallography—GLX2-5 was prepared and purified as
described under “Overexpression and Purification of Arabidopsis
GLX2-5.” Enzyme purity was ascertained by SDS-PAGE to be ⬎95%,
and the concentration was 12 mg/ml (0.4 mM). The sample (2 ml) was
drop-frozen in liquid nitrogen and shipped on dry ice to the Center for
Eukaryotic Structural Genomics, University of Wisconsin, Madison.
The coordinates have been deposited in the Protein Data Bank (accession number 1XM8).
Molecular Weight Determination—Approximately 5 mg of GLX2-5
was mixed with 7 mg of ovalbumin, 10 mg of ribonuclease A, and 1 mg
of blue dextran and subjected to chromatography through a Sephadex
S200 column in 10 mM MOPS, pH 7.2, containing 0.15 M NaCl. The flow
rate was 1 ml/min, and 2.0-ml fractions were collected. Samples containing protein were identified by monitoring A280 and by SDS-PAGE. A
sample of GLX2-5 was run as a control.

Structure of Mitochondrial Glyoxalase 2

Fe(III). These two components are commonly seen in the EPR spectra of
metalloenzymes and are present at low levels in the spectrum of
GLX2-5. Integration of the spectra of S ⬎1⁄2 species is notoriously unreliable, especially when D is small and multiple Kramers’ doublets are
populated, some of which have resonances for which geff. tends to zero.
Nevertheless, in the present case the experimental spectrum, trace A,
can be compared with a simulated spectrum, trace D, that does not
contain these components. The six-line Mn(II) signal and the geff. ⫽ 4.3
isotropic signal are not major components of the spectrum of GLX2-5
and are likely irrelevant to the structure and function of the active site;
therefore, they were not studied further.
The major species in the EPR spectrum of GLX2-5 can be confidently
assigned to an unusual, protein-bound, magnetically isolated Fe(III) ion
on the basis of computer simulation. The experimental spectrum (Fig. 2,
trace A) shows a peak at 750 G (geff. ⫽ 9.01), a broad peak at 1410 G, a
derivative at 1595 G (geff. ⫽ 4.25 G), and a shoulder at 1815 G with broad
underlying absorption. Considering the sensitivities of the intensities,
resonance positions, and line shapes of these features to not only the
zero-field splitting parameters themselves but, in particular, to the
effects of strains in g, D, and E, the theoretical spectrum shown as Fig. 1,
trace D, reproduces the features of the experimental spectrum remarkably well. The detailed parameters used for the simulation are given in
the legend to Fig. 1, but the salient points are as follows: (i) an isotropic
g ⫽ 2.0; (ii) a moderately rhombic E/D; (iii) an unusually low value for D,
barely larger than the microwave quantum; and (iv) significant strains in
the zero-field splitting parameters. The simulations were extremely
sensitive to D, E/D, ⌬D, and ⌬E; the simulation rapidly becomes unrecognizable as being related to the experimental spectrum upon changing
these values, and we estimate maximum errors of ⫾15% for each of
these parameters. The main deficiencies of the simulation are the
imperfect reproduction of the sharp spike at geff. ⬃4.2 and the underestimation of the intensity of the broad absorption from 1600 to 2200 G.
Both of these are likely the result of the overlapping isotropic geff. ⫽ 4.3
signal due to adventitious Fe(III), although it is possible that the strains
in the zero-field splitting parameters have a more complex distribution
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than the simple one used in the present work. An additional minor
difference between the simulation and experimental spectra is the presence of sharp but very weak features at ⬃3750 and ⬃4500 G in the
simulation that are not observed experimentally; either strains in g or
relaxation effects may be responsible for the absence of these features in
the experimental spectrum.
The EPR spectrum of GLX2-5 contained, in addition to the proteinbound Fe(III) that constituted the major species, a rhombic signal with
apparent S ⫽ 1⁄2 and geff. values of 1.93, 1.87, and 1.73 (Fig. 2, trace B). As
we are unaware of any mononuclear S ⫽ 1⁄2 ions that were likely to be
present in our preparation that would give rise to these parameters, we
were prompted to seek an alternative assignment for this signal. The
signal was well simulated, assuming a strongly anti-ferromagnetically
spin-coupled Fe(II)-Fe(III) system and assuming an isotropic gFe(III) ⫽
2.0, a rhombic gFe(II) with g ⬎2.0, and J ⬎⬎h. It should be pointed out
that there is no unique parameter set for generating this spectrum (or
others very similar to it), and the detailed parameters used to obtain Fig.
2, trace D, are given in the figure legend mainly for reference. However,
they do also serve to illustrate that the otherwise uninterpretable signal
at geff. ⫽ 1.93, 1.87, and 1.73 can be interpreted in terms of an Fe(II)Fe(III) mixed valence center using reasonable values for g, individual
zero-field splittings, and exchange coupling. Assuming that the signal is
indeed due to a di-iron center, and with caveats regarding the quantification of the major S ⫽ 5/2 signal in mind, we estimated that the geff. ⫽
1.93, 1.87, 1.73 signal accounts for up to a maximum of 20% of the total
protein-bound iron.
In order to probe further the active site structure of GLX2-5, a 1H
NMR spectrum of GLX2-5 was obtained (Fig. 3). There were at least
eight paramagnetically shifted resonances in-between 110 and ⫺30
ppm. Previous studies have shown that the T1e of Fe(III) when part of a
Fe(III)Zn(II) center is too slow to observe paramagnetically shifted 1H
resonances (48, 49). Therefore, the peaks observed in Fig. 3 must be due
to ligands bound to a Fe(III)Fe(II) center in the sample., Peaks a, c, d, and
f of Fig. 3 integrate to two protons, whereas peaks b, g, and h integrate to
nearly 1 proton each. Peaks a and d of Fig. 3 are solvent-exchangeable,
and based on their resonance positions and line widths, these peaks can
be assigned to N-H protons on Fe(III)- and Fe(II)-bound histidines,
respectively (48, 50, 51). This result suggests that there are at least four
histidines bound to the Fe(III)Fe(II) center in this sample. If GLX2-5 is
similar to human GLX2-2 then there should be five histidines bound to
the metal center. It is possible that a fifth solvent-exchangeable NH
resonance is not observed due to fast exchange with bulk solvent (49,

JOURNAL OF BIOLOGICAL CHEMISTRY

40671

Downloaded from http://www.jbc.org/ at MARQUETTE UNIV on October 15, 2020

FIGURE 2. EPR spectrum of GLX2-5. Trace A shows the spectrum of GLX2-5 recorded at
4.7 K. The inset shows an expanded view of the g ⬃1.9 region of the spectrum (trace B)
and a theoretical spectrum (trace C). The theoretical spectrum was generated using the
spin Hamiltonian H ⫽ ␤g1.B.S1 ⫹ S1.D1.S1 ⫹ ␤g2.B.S2 ⫹ S2.D2.S2 ⫹ J.S1.S2, where S1 ⫽ 5/2;
g1(iso) ⫽ 2.0; D1 ⫽ 3 cm⫺1; E1 ⫽ 0; S2 ⫽ 1; g2(x,y,z) ⫽ 2.093, 2.192, and 2.322; D2 ⫽ 10 cm⫺1;
E ⫽ 0; and J ⫽ 50 cm⫺1. This scheme represents a strongly anti-ferromagnetically coupled Fe(III)-Fe(II) center. Trace D shows a composite simulation of the experimental EPR
spectrum. The simulation has two components, one of which is that shown as trace C,
and another, the major component, corresponds to an isolated Fe(III) ion with H ⫽ ␤g.B.S
⫹ S.D.S, where g(iso) ⫽ 2.0; S ⫽ 5/2; D ⫽ 0.45 cm⫺1; E ⫽ 0.0855 cm⫺1 (E/D ⫽ 0.19); ⌬D ⫽
0.20 cm⫺1; and ⌬E ⫽ 0.057 cm⫺1. An additional component with an isotropic g(eff) ⫽ 4.3
is present but was not included in the simulation.

FIGURE 3. NMR spectrum of 1. 6 mM GLX2-5. NMR spectra were collected on a Bruker
Avance 500 spectrometer operating at 500.13 MHz, 298 K, and a magnetic field of 11.7
tesla, recycle delay (AQ), 41 ms; sweep width, 400 ppm. Protein chemical shifts were
calibrated by assigning the H2O signal the value of 4.70 ppm. A modified presaturation
pulse sequence (zgpr) was used to suppress the proton signals originating from water
molecules. *, solvent-exchangeable peaks.

Structure of Mitochondrial Glyoxalase 2
52). The solvent-exchangeable, upfield shifted peak h is very unusual
because very few metal-binding amino acid ligands are solvent-exchangeable, and none are known to yield upfield shifted peaks. An
upfield shift is suggestive of a , rather than , delocalization mechanism (50). A similarly shifted, solvent-exchangeable peak was observed
in Fe(III)Fe(II)-containing uteroferrin; however, the assignment of this
peak has not been made (50). It has been suggested that this peak arises
from a backbone NH in close proximity to the metal center (53).
Although unambiguous assignments of the remaining peaks are not
possible, it is likely that peaks b and c are due to either meta protons
(⫺CH) on Fe(II)-bound histidines or to ␤-CH2 protons on metal-bound
histidines (49, 50). Ortho protons on metal-bound histidines are usually
too broad to detect (50). Peaks f and g are probably due to ␤-CH2
protons on bound Asp/Glu ligands (49, 50). Therefore, the NMR spec-

TABLE ONE

Comparisons of the active sites of human GLX2-2 and A. thaliana GLX2-5
Structures for human GLX2-2 (Protein Data Bank number 1QH3) and A. thaliana GLX2-5 (Protein Data Bank number 1XM8) were analyzed with Raswin version
2.7.2.1.
Bond
angle (o)b

Second sphere
ligands

Metala

Enzyme

Residue

Atom

Distance

M1

GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2
GLX2-5
GLX2-2

His-54
His-54
His-56
His-56
His-112
His-110
Bridging H2O/OH⫺

N-⑀2
N-⑀2
N-␦1
N-␦1
N-⑀2
N-⑀2

2.1
2.3
2.1
2.3
2.1
2.3
2.0
2.1

119
104
104
95
129
161

Thr-53

O-␦2
O-␦2
O-␦2
N-⑀2
N-⑀2
O-␦2
O-␦2
N-⑀2
N-⑀2

2.2
2.0
2.3
1.9
2.2
2.0
2.2
1.9
2.1
2.1
2.1

78
90
87
107
101
81
78
141
151

Asp-134 carbonyl

Å

M1
M1
M1
M1
M2
M2
M2
M2
M2
a
b

None
Asp-134
Asp-58
Asp-58
His-59
His-59
Asp-131
Asp-134
His-169
His-173
Bridging H2O/OH⫺

Glu-146 via water
Lys-140 carbonyl

Asp-29

Asp-11

M1 is Zn(II) for both enzymes; M2 is Zn(II) for human GLX2-2 and Fe for A. thaliana GLX2-5.
Bond angle is defined as the bridging H2O/OH⫺ - metal-ligating atom of ligand.
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FIGURE 4. Ribbon structure of GLX2-5 from A. thaliana. The coordinates have been
deposited in the Protein Data Bank (accession number 1XM8). Figure was rendered using
Raswin Molecular Graphics, Windows version 2.7.2.1.1.

trum of GLX2-5 confirmed the presence of an Fe(III)Fe(II) center in the
enzyme.
Crystallographic Studies on GLX2-5—Alignment of GLX2-5 with
human GLX2 (Fig. 1) indicated that the proteins share modest sequence
identity (37% identical). The largest blocks of identical residues are present around residues identified as metal-binding ligands in the human
enzyme. Other regions (amino acids 69 –132 and 187–257) demonstrated less sequence conservation. Furthermore, if GLX2-5 contains a
Fe(III)Zn(II) structure as we predict, then the geometries of the metal
centers of the two enzymes should differ. Therefore, the x-ray crystal
structure of GLX2-5 at pH 4.5 was solved to 1.74 Å resolution and is
shown in Fig. 4 (TABLES ONE and TWO). The enzyme crystallized as
a dimer with monomers of 254 amino acids, and each monomer has an
␣␤␤␣ motif, which is found in all enzymes containing a metallo-␤lactamase fold (44). The interface between the two monomers contains
Lys-10, His-56, Tyr-57, Lys-140, Phe-142, Glu-143, Lys-177, Lys-203,
Asp-253, and Phe-254 from both subunits. The dimer is held together
by a number of electrostatic interactions such as Lys-10 forming contacts with Asp-11 and Glu-170, Asp-253 forming a contact with His-56,
and Phe-254 hydrogen bonding to Tyr-57. One molecule of acetate was
found in each subunit and was located near (distances ⬍3.0 Å) Arg-248,
Lys-251, Lys-140, and Ser-137. One molecule of PEG was found in subunit A and was shown to be positioned near Lys-202. The C terminus of
each monomer lies in the dimer interface, which is solvent-accessible,
whereas the N termini are solvent-exposable.
Each monomer binds two heavy atoms, and the metal ions are bound
near the surfaces of the monomers in-between the ␤-sheets of the ␣␤␤␣
motif. Because EPR studies predicted that a Fe(III)Zn(II) center is predominant in recombinant GLX2-5, this center is shown in Figs. 4 and 5.
However, we cannot completely rule out the possibility of a dinuclear Fe
or Zn center. The metal centers face one another with the metal ion in
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TABLE TWO

Crystallographic and refinement statistics
Additional details about crystallographic and refinement statistics can be
found on the Protein Data Bank, Research Collaboratory for Structural Bioinformatics website (Protein Data Bank number 1XM8).

a

1XM8
P1 21 1
33.71–1.74
51,949
7.9 (54.5)
21.2 (4.3)
95.4 (97.4)
17.9 / 28.4
0.020
1.7
547
SADb

Values for the highest resolution shell are in parentheses.
SAD is single wavelength anomalous diffraction.

FIGURE 5. Active sites of (left) GLX2-2 from human and (right) GLX2-5 from A. thaliana. Figure was rendered using Raswin Molecular Graphics, Windows version 2.7.2.1.1.

site 1 of each subunit being 17.8 Å apart (Fig. 4). The metal ions in each
subunit are separated by 3.3 (4) Å (Fig. 5). The metal ion in site 1 is
coordinated tetrahedrally by His-54, His-56, His-112, and a bridging
water/hydroxide (TABLE ONE). The metal ion in site 2 is coordinated
in a trigonal bipyramid geometry by Asp-58, His-59, Asp-131, His-169,
and a bridging water/hydroxide, with Asp-131 and Asp-58 in the apical
positions of the trigonal bipyramid. One oxygen (O-␦1) of Asp-58
appears to be in position (2.78 Å from bridging hydroxide oxygen) to
form a hydrogen bond to the bridging water/hydroxide. A similar role
was predicted for Asp-120 in metallo-␤-lactamase L1 (2.83 Å from O-␦1
to hydroxide oxygen) (43).
The crystal structure of human GLX2 complexed with glutathione
and S-hydroxybromophenylcarbamoyl glutathione showed that Arg249, Lys-252, Lys-143, Tyr-175, and Tyr-145 are within 13 Å of the
metal ion in site 1 and interact with glutathione and S-hydroxybromophenylcarbamoyl glutathione. Alignment of the amino acid sequences
of human GLX2 and GLX2-5 (Fig. 1) shows that all of the glutathione
and inhibitor-binding residues of human GLX2 are conserved in
GLX2-5 except Tyr-145, which is replaced by a Phe in GLX2-5. Phe142, Tyr-171, Arg-248, Lys-140, and Lys-251 are all within 13 Å of the
metal ion in site 1 of GLX2-5. Therefore, we predicted that these ligands
are involved in substrate binding.
One common structural feature of enzymes that have a metallo-␤lactamase fold is an extensive H-bonding network around the metalbinding ligands (TABLE ONE). In particular, the ligands that coordinate
the metal ion in site 2 typically form hydrogen bonds to two Asp residues. In GLX2-5, His-169 (N-␦1) forms an H-bond with O-␦1 of Asp-11
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FIGURE 6. Elution profile from gel filtration column. Approximately 5 mg of GLX2-5, 7
mg of ovalbumin, 10 mg of ribonuclease A, and 1 mg of blue dextran were separated on
a Sephadex S200 column. Samples containing protein were identified by monitoring
A280 and by SDS-PAGE.

(2.86 Å), and Asp-11 (O-␦2) forms a hydrogen bond with the side chain
of Lys-10. The O-␦2 oxygen of Asp-11 is also positioned to hydrogenbond to a solvent molecule, which H-bonds to a second solvent molecule that hydrogen-bonds to Asp-11 (O-␦2) in molecule B of the structure. The N-␦1 nitrogen of His-59 forms a hydrogen bond to the O-␦2 of
Asp-29 (2.819 Å), whereas the O-␦1 oxygen of Asp-29 forms a hydrogen
bond to the backbone amine of Thr-53. The metal-binding ligands in
site 2 also form hydrogen bonds with amino acids near the active site:
N-␦1 of His-54 hydrogen bonds to the O-␥1 of Thr-53, and the carbonyl
oxygen of Lys1– 40 (which corresponds to Lys-143 in human GLX2)
forms a hydrogen bond with the N-␦1 of His-112. Therefore, a similar
hydrogen bonding network is conserved in GLX2-5.
GLX2-5 Exists as a Monomer in Solution—In contrast to the situation
in the crystal structure, GLX2-5 was found to exist as a monomer when
a sample of recombinant protein was subjected to gel filtration chromatography (Fig. 6). GLX2-5 was found to elute between ovalbumin (44
kDa) and ribonuclease A (13 kDa) during gel filtration chromatography.
The molecular mass of the recombinant GLX2-5 monomer is 28.2 kDa,
whereas a dimer would be expected to run as a 56-kDa protein. It is
possible that weak interactions between the GLX2-5 monomers result
in some dimerization of the enzyme in the cell that are disrupted by the
ionic strength of the buffer during gel filtration. However, it is more
likely that the dimers observed in the crystal structure of both GLX2-5
and human GLX2 are likely the result of the conditions used for
crystallization.

DISCUSSION
Mitochondrial GLX2-5 from A. thaliana was successfully overexpressed and purified with single step chromatography. The resulting
protein was shown to bind significant amounts of both Fe and Zn(II),
but unlike Arabidopsis GLX2-2 (40, 41), very little Mn was bound to the
enzyme. The complex EPR spectra of GLX2-5 are very reminiscent of
those of Arabidopsis GLX2-2 (40, 41), which contain overlapping signals that have been assigned to Fe(III)Zn(II), anti-ferromagnetically
coupled Fe(III)Fe(II), and ferromagnetically coupled Mn(II)Mn(II) centers. However, there are no signals that could be assigned to a ferromagnetically coupled Mn(II)Mn(II) center in the spectrum of GLX2-5, and
the relatively weak, multiline signal at g ⬃2 is probably due to adventitiously bound, mononuclear Mn(II). The EPR spectrum of GLX2-5 does
suggest the presence of a magnetically uncoupled Fe(III) center that,
given the metal analyses and precedents in the literature (45, 54, 55), can
be assigned to a Fe(III)Zn(II) center. This center is the predominant one
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human GLX2 (42), and these same residues form hydrogen bonds with
metal-binding ligands of site 2 in GLX2-5. The different metal contents
of the two enzymes cannot be directly attributed to different metal
ligands, but may be related to different second sphere interactions. Two
of the second sphere ligands in human GLX2 (Thr-53 and Lys-143
(Lys-140 in GLX2-5)) form interactions with His residues of site 1 in
GLX2-5. However, two key second sphere ligand interactions observed
in the structure of human GLX2 are missing in GLX2-5. Glu-146 (incorrectly labeled Asp-146 in Table 1 of Ref. 42) was shown to interact with
His-56, via a water molecule, in the structure of human GLX2. There is
no evidence of a water molecule in the structure of GLX2-5 between
His-56 and Glu-143, and these two residues are 5.2 Å apart and probably
do not interact. The structure of human GLX2 also suggested an interaction of the carbonyl of Asp-134 with the side chain of Asp134 (42); this
interaction is not observed in GLX2-5. At this time it is not clear if these
differences in second sphere influence the metal binding properties of
the enzyme or if they result from the different geometries of the metal
centers in GLX2-5.
Results presented in this study represent the first detailed structural
characterization of a mitochondrial glyoxalase 2 isozyme from any
source. Our results indicate that although the Arabidopsis GLX2
isozymes can utilize a number of different metal centers, it appears that
a Fe(III)Zn(II) center is the predominant form of GLX2-5. Although
further studies are required on other GLX2 and ␤-lactamase fold-containing enzymes to better understand factors that control metal specificity in these enzymes, our results suggest that subtle alterations in
second sphere ligands may directly affect metal preference and geometry in GLX2 enzymes. Differences in second sphere ligands may explain
why human GLX2 appears to have a preference for a dinuclear Zn site,
whereas the majority of recombinant Arabidopsis GLX2-5 contains a
Fe(III)Zn(II) site. What role, if any, differences in metal center preference and geometry play in the catalytic mechanism remains to be
determined.
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in GLX2-5 accounting for nearly 70% of the EPR-active Fe(III) in the
spectrum. There is also a significant amount of an anti-ferromagnetically coupled Fe(III)Fe(II) center, which accounts for nearly 30% of the
Fe in the sample. Because there are roughly equal amounts of Fe and Zn
in GLX2-5, there must also be a significant amount of dinuclear Zn(II)containing enzyme in this sample. Therefore, like recombinant GLX2-2
(40, 41), recombinant mitochondrial GLX2-5 contains a mixture of
metal centers.
The 1H NMR spectrum of GLX2-5 arises from protons in close proximity to the Fe(III)Fe(II) center in the sample. The crystal structure of
GLX2-5 (Fig. 5) shows that there are five bound histidines to the metal
center; however, the NMR spectra only revealed four solvent-exchangeable NH resonances. The crystal structure (Fig. 5) shows that the NH
group on His-56 is pointed directly into the media, and this positioning
provides an excellent explanation of why the fifth solvent-exchangeable
NH resonance is not observed. His-56 is also the only histidine that is
bound via the ␦N; therefore, there would only be one meta-CH proton
expected in the NMR spectrum. Previous model studies by Que and
co-workers (50) revealed that meta protons on imidazoles/histidines
bound to Fe(III) exhibit resonance lines from 70 to 90 ppm, whereas
those bound to Fe(II) exhibit resonances from 30 to 60 ppm. Because
there are no resonances in the 70 –90-ppm region (Fig. 3) that could be
assigned to a meta proton, this result indicates that His-56 is coordinated to an Fe(II). Because it is most likely that Zn(II) will replace Fe(II)
in the Fe(III)Zn(II) analog of GLX2-5, this result suggests that the metal
bound in the site containing His-56 in Fig. 5 is Zn(II).
To probe further the structure of GLX2-5, the enzyme was sent to the
Center for Eukaryotic Structural Genomics for crystal structure determination. Even though our spectroscopic results indicate that the
GLX2-5 sample is heterogeneous in terms of metal centers, this sample
yielded suitable crystals for structure determination. Although similar
in many ways, the crystal structures of human GLX2 and GLX2-5 show
some significant structural differences between the two enzymes. Both
enzymes crystallized as dimers; however, the dimer interface in human
GLX2 is made up entirely of ␣-helices in the C termini of the monomers.
The metal centers in human GLX2 face each other but are separated by
⬎36 Å. Conversely, the dimer interface in GLX2-5 is extensive with
multiple interactions between amino acids in each monomer and a
Zn(II)-Zn(II) distance of 18 Å (Fig. 4).
Perhaps more interesting are our results concerning the metal centers in the two enzymes, which also show several differences. The crystal
structure of human GLX2 showed two Zn(II) ions separated by 3.4 –3.5
Å, and each Zn(II) was coordinated by six ligands in an octahedral
geometry (42). The metal ions in GLX2-5 are coordinated by the same
amino acid ligands that coordinate the Zn(II) ions in human GLX2.
However, there is no evidence for additional solvent molecules coordinated to the metal ions in GLX2-5, and the metal ions have trigonal
bipyramidal and tetrahedral geometries. The Zn(II) ions in human
GLX2 are bridged by a hydroxide and by O-␦2 of Asp-134 (42), whereas
there is no evidence of a bridging Asp (Asp-131) in GLX2-5. Despite
missing the bridging Asp, the M–M bond distance is 0.1 Å shorter in
GLX2-5 than in the human enzyme (42). In addition, the metal-ligand
distances are shorter in GLX2-5 than in human GLX2-2 (TABLE ONE).
There are also large differences in the bond angles (bridging hydroxide/
water-metal-atom in ligand) in the active sites of the two enzymes
(TABLE ONE).
Despite the differences in metal ions and their geometry and in some
first sphere ligands in human GLX2 and GLX2-5, the hydrogen bonding
network around the metal centers is remarkably conserved. Asp-11 and
Asp-29 form H-bonds to the metal-binding histidines in the Zn2 site of
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